Literature DB >> 22054939

Marine algal sources for treating bacterial diseases.

M L Arvinda Swamy1.   

Abstract

Microorganisms are the causative agents for various types of diseases in humans, animals, and plants. The invention of antibiotics against the bacterial diseases in the early twentieth century improved the heath conditions of the humans, but it resulted in the development of variable drug/multidrug-resistant strains which are now posing great challenge to cure the diseases. The need for searching novel bioactive compounds having potential therapeutic value resulted in exploration of oceans. Screening diverse fauna and flora in oceans opened new avenues for the development of novel therapeutic agents such as sesquiterpenes, phlorotannins, bromoditerpenes, halogenated furanones, and algal lectin which show effect on a wide range of Gram-negative and positive bacteria. Hence these bioactive compounds can be used as broad spectrum antibiotics, antibacterial, and antifouling agents.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054939     DOI: 10.1016/B978-0-12-387669-0.00006-5

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  8 in total

1.  Sesquiterpene and Sorbicillinoid Glycosides from the Endophytic Fungus Trichoderma longibrachiatum EN-586 Derived from the Marine Red Alga Laurencia obtusa.

Authors:  Ying Wang; Xiao-Ming Li; Sui-Qun Yang; Fan-Zhong Zhang; Bin-Gui Wang; Hong-Lei Li; Ling-Hong Meng
Journal:  Mar Drugs       Date:  2022-02-28       Impact factor: 5.118

2.  Antimicrobial and Antibiofilm Activities of Sulfated Polysaccharides from Marine Algae against Dental Plaque Bacteria.

Authors:  Joon-Young Jun; Min-Jeong Jung; In-Hak Jeong; Koji Yamazaki; Yuji Kawai; Byoung-Mok Kim
Journal:  Mar Drugs       Date:  2018-08-27       Impact factor: 5.118

3.  Transcriptional response of cultured porcine intestinal epithelial cells to micro algae extracts in the presence and absence of enterotoxigenic Escherichia coli.

Authors:  Marcel Hulst; Rommie van der Weide; Arjan Hoekman; Marinus van Krimpen
Journal:  Genes Nutr       Date:  2019-03-19       Impact factor: 5.523

Review 4.  Algal lectins as promising biomolecules for biomedical research.

Authors:  Ram Sarup Singh; Shivani Rani Thakur; Parveen Bansal
Journal:  Crit Rev Microbiol       Date:  2013-07-16       Impact factor: 7.624

Review 5.  An Overview of Potential Seaweed-Derived Bioactive Compounds for Pharmaceutical Applications.

Authors:  Silvia Lomartire; Ana M M Gonçalves
Journal:  Mar Drugs       Date:  2022-02-15       Impact factor: 5.118

6.  Characterization of isoforms of the lectin isolated from the red algae Bryothamnion seaforthii and its pro-healing effect.

Authors:  Luiz Gonzaga do Nascimento-Neto; Romulo Farias Carneiro; Suzete Roberta Da Silva; Bruno Rocha Da Silva; Francisco Vassiliepe Sousa Arruda; Victor Alves Carneiro; Kyria Santiago Do Nascimento; Silvana Saker-Sampaio; Valdemiro Amaro Da Silva; Ana Lúcia Figueiredo Porto; Benildo Sousa Cavada; Alexandre Holanda Sampaio; Edson Holanda Teixeira; Celso Shiniti Nagano
Journal:  Mar Drugs       Date:  2012-09-04       Impact factor: 6.085

Review 7.  Seaweeds as a Functional Ingredient for a Healthy Diet.

Authors:  Rocío Peñalver; José M Lorenzo; Gaspar Ros; Ryszard Amarowicz; Mirian Pateiro; Gema Nieto
Journal:  Mar Drugs       Date:  2020-06-05       Impact factor: 5.118

8.  Bioactive Polyphenols from Southern Chile Seaweed as Inhibitors of Enzymes for Starch Digestion.

Authors:  Luz Verónica Pacheco; Javier Parada; José Ricardo Pérez-Correa; María Salomé Mariotti-Celis; Fernanda Erpel; Angara Zambrano; Mauricio Palacios
Journal:  Mar Drugs       Date:  2020-07-08       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.